育龄期月经周期规律性与长度及心血管疾病风险
该前瞻性队列研究纳入护士健康研究II的80630名参与者,随访1993年至2017年,评估14-17岁、18-22岁及29-46岁时的月经周期规律性与长度,主要终点为致死性或非致死性冠心病(心肌梗死或冠脉血运重建)和卒中。多因素Cox模型显示,与同期周期非常规律者相比,14-17岁、18-22岁、29-46岁周期不规律或无月经者CVD的HR分别为1.15(95%CI 0.99-1.34)、1.36(95%CI 1.06-1.75)、1.40(95%CI 1.14-1.71);与周期长度26-31天者相比,18-22岁或29-46岁周期长度≥40天或过于不规律无法估计者CVD的HR分别为1.44(95%CI 1.13-1.84)和1.30(95%CI 1.09-1.57)。中介分析显示,后续发生的高胆固醇血症、慢性高血压和2型糖尿病仅解释5.4%至13.5%的关联。
要点
- 与14-17岁周期非常规律者相比,该年龄段周期不规律或无月经者CVD的HR为1.15(95%CI 0.99-1.34),未达统计学显著。
- 与18-22岁周期非常规律者相比,该年龄段周期不规律或无月经者CVD的HR为1.36(95%CI 1.06-1.75)。
- 与29-46岁周期非常规律者相比,该年龄段周期不规律或无月经者CVD的HR为1.40(95%CI 1.14-1.71)。
- 与周期长度26-31天者相比,18-22岁或29-46岁周期长度≥40天或过于不规律无法估计者CVD的HR分别为1.44(95%CI 1.13-1.84)和1.30(95%CI 1.09-1.57)。
- 高胆固醇血症、慢性高血压和2型糖尿病仅解释5.4%至13.5%的关联。
适用人群与场景
- 护士健康研究II参与者,1993年基线平均年龄37.7岁(SD 4.6),平均体重指数25.1(SD 5.6)。
- 纳入分析者需在1989年入组时报告14-17岁和18-22岁的月经周期规律性与长度,并在1993年(29-46岁)更新当前周期特征。
研究设计与关键结果
- 研究类型:前瞻性队列研究,纳入80630名护士健康研究II参与者,随访1993年至2017年(24年),共1816名女性发生首次CVD事件。
- 暴露:14-17岁、18-22岁及29-46岁的月经周期规律性与长度。
- 主要终点:致死性和非致死性冠心病(心肌梗死或冠脉血运重建)及卒中。
- 与同期周期非常规律者相比,14-17岁、18-22岁、29-46岁周期不规律或无月经者CVD的HR分别为1.15(95%CI 0.99-1.34)、1.36(95%CI 1.06-1.75)、1.40(95%CI 1.14-1.71)。
- 与周期长度26-31天者相比,18-22岁或29-46岁周期长度≥40天或过于不规律无法估计者CVD的HR分别为1.44(95%CI 1.13-1.84)和1.30(95%CI 1.09-1.57)。
- 中介分析:后续发生的高胆固醇血症、慢性高血压和2型糖尿病仅解释5.4%至13.5%的关联。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
- 作者结论:月经周期不规律和过长与CVD发生率升高相关,且在考虑后续 established CVD危险因素后仍持续存在。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Menstrual cycle characteristics may be associated with an increased risk of cardiovascular disease (CVD). However, existing studies are limited, and few have explored the mediating role of established CVD risk factors.
OBJECTIVE: To explore the associations of menstrual cycle characteristics across the reproductive lifespan with the risk of CVD and to what extent these associations were mediated by hypercholesterolemia, chronic hypertension, and type 2 diabetes.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study prospectively followed Nurses' Health Study II participants between 1993 and 2017 who reported menstrual cycle regularity and length for ages 14 to 17 years and 18 to 22 years at enrollment in 1989 and updated current cycle characteristics in 1993 (at ages 29 to 46 years). Data analysis was performed from October 1, 2019, to January 1, 2022.
EXPOSURES: Menstrual cycle regularity and length across the reproductive lifespan.
MAIN OUTCOMES AND MEASURES: Incident CVD events of interest, including fatal and nonfatal coronary heart disease (CHD; myocardial infarction [MI] or coronary revascularization) and stroke.
RESULTS: A total of 80 630 Nurses' Health Study II participants were included in the analysis, with a mean (SD) age of 37.7 (4.6) years and body mass index of 25.1 (5.6) at baseline. Over 24 years of prospective follow-up, 1816 women developed their first CVD event. Multivariable Cox proportional hazards models showed that, compared with women reporting very regular cycles at the same ages, women who had irregular cycles or no periods at ages 14 to 17, 18 to 22, or 29 to 46 years had hazard ratios for CVD of 1.15 (95% CI, 0.99-1.34), 1.36 (95% CI, 1.06-1.75), and 1.40 (95% CI, 1.14-1.71), respectively. Similarly, compared with women reporting a cycle length of 26 to 31 days, women reporting a cycle length 40 days or more or a cycle too irregular to estimate from ages 18 to 22 or 29 to 46 years had hazard ratios for CVD of 1.44 (95% CI, 1.13-1.84) and 1.30 (95% CI, 1.09-1.57), respectively. Mediation analyses showed that subsequent development of hypercholesteremia, chronic hypertension, and type 2 diabetes only explained 5.4% to 13.5% of the observed associations.
CONCLUSIONS AND RELEVANCE: In this cohort study, both irregular and long menstrual cycles were associated with increased rates of CVD, which persisted even after accounting for subsequently established CVD risk factors.
参考来源
- Wang YX, Stuart JJ, Rich-Edwards JW, et al. Menstrual Cycle Regularity and Length Across the Reproductive Lifespan and Risk of Cardiovascular Disease. JAMA Netw Open. 2022. PMID: 36282498. doi:10.1001/jamanetworkopen.2022.38513
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。